| mRNA |
Parthenolide |
GDSC1000 |
pan-cancer |
AAC |
-0.0096 |
0.9 |
| mRNA |
BIRB 0796 |
FIMM |
pan-cancer |
AAC |
-0.032 |
0.9 |
| mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |
| mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
| mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.0075 |
0.9 |
| mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
KIN001-270 |
GDSC1000 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
-0.0092 |
0.9 |
| mRNA |
paclitaxel |
GDSC1000 |
pan-cancer |
AAC |
0.0084 |
0.9 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |